# A Study To Investigate The Safety And Efficacy Of CP- 690,550 In Patients With Moderate And Severe Ulcerative Colitis.

> **NCT00787202** · PHASE2 · COMPLETED · sponsor: **Pfizer** · enrollment: 195 (actual)

## Conditions studied

- Ulcerative Colitis

## Interventions

- **DRUG:** CP- 690 550
- **DRUG:** CP- 690 550
- **DRUG:** CP- 690 550
- **DRUG:** CP- 690 550
- **OTHER:** placebo

## Key facts

- **NCT ID:** NCT00787202
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-12
- **Primary completion:** 2010-09
- **Final completion:** 2010-09
- **Target enrollment:** 195 (ACTUAL)
- **Last updated:** 2013-04-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00787202

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00787202, "A Study To Investigate The Safety And Efficacy Of CP- 690,550 In Patients With Moderate And Severe Ulcerative Colitis.". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00787202. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*